Mortality in COPD: Causes, Risk Factors, and Prevention

REFERENCES

• National Institutes of Health. National Heart, Lung, and Blood Institute (NHLBI). Morbidity and mortality: 2009 chartbook on cardiovascular, lung, and blood diseases. 2009 October 2009.
   Google Scholar
• Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 1997 May 24; 349(9064):1498–504.
   PubMed Web of Science ®Google Scholar
• Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970–2002. JAMA 2005 Sep 14; 294(10):1255–9.
   PubMed Web of Science ®Google Scholar
• Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: Role of co-morbidities. Eur Respir J 2006 Dec;28(6):1245–57.
   PubMed Web of Science ®Google Scholar
• Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance—United States, 1971–2000. MMWR Surveill Summ 2002 Aug 2;51(6):1–16.
   Google Scholar
• Coultas DB, Mapel D, Gagnon R, Lydick E. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med 2001 Aug 1; 164(3):372–377.
   PubMed Web of Science ®Google Scholar
• Coultas DB, Mapel DW. Undiagnosed airflow obstruction: prevalence and implications. Curr Opin Pulm Med 2003 Mar; 9(2):96–103.
   PubMed Web of Science ®Google Scholar
• Lundback B, Lindberg A, Lindstrom M, Ronmark E, Jonsson AC, Jonsson E, Not 15 but 50% of smokers develop COPD?—Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003 Feb; 97(2):115–122.
   PubMed Web of Science ®Google Scholar
• Drummond MB, Wise RA, John M, Zvarich MT, McGarvey LP. Accuracy of death certificates in COPD: analysis from the TORCH trial. COPD 2010 Jun; 7(3):179–185.
   PubMedGoogle Scholar
• Higgins MW, Keller JB. Trends in COPD morbidity and mortality in Tecumseh, Michigan. Am Rev Respir Dis 1989 Sep; 140(3 Pt 2):S42–48.
   Google Scholar
• Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 2003 May; 58(5):388–393.
   PubMed Web of Science ®Google Scholar
• Bang KM, Gergen PJ, Kramer R, Cohen B. The effect of pulmonary impairment on all-cause mortality in a national cohort. Chest 1993 Feb; 103(2):536–540.
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 2005 Feb 15; 142(4):233–239.
   PubMed Web of Science ®Google Scholar
• Pauwels RA, Lofdahl CG, Laitinen LA, Schouten JP, Postma DS, Pride NB, Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med 1999 Jun 24; 340(25):1948–1953.
   PubMed Web of Science ®Google Scholar
• Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000 May 13; 320(7245):1297–1303.
   PubMed Web of Science ®Google Scholar
• Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007 Feb 22; 356(8):775–789.
   PubMed Web of Science ®Google Scholar
• McGarvey LP, John M, Anderson JA, Zvarich M, Wise RA. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax 2007 May; 62(5):411–415.
   PubMed Web of Science ®Google Scholar
• Celli B, Decramer M, Kesten S, Liu D, Mehra S, Tashkin DP. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009 Nov 15; 180(10):948–955.
   PubMed Web of Science ®Google Scholar
• Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008 Oct 9; 359(15):1543–1554.
   PubMed Web of Science ®Google Scholar
• Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004 Mar 4; 350(10):1005–1012.
   PubMed Web of Science ®Google Scholar
• Zielinski J, MacNee W, Wedzicha J, Ambrosino N, Braghiroli A, Dolensky J, Causes of death in patients with COPD and chronic respiratory failure. Monaldi Arch Chest Dis 1997 Feb; 52(1):43–47.
   PubMedGoogle Scholar
• Anthonisen NR, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986 Jan; 133(1):14–20.
   PubMed Web of Science ®Google Scholar
• Traver GA, Cline MG, Burrows B. Predictors of mortality in chronic obstructive pulmonary disease. A 15-year follow-up study. Am Rev Respir Dis 1979 Jun; 119(6):895–902.
   PubMed Web of Science ®Google Scholar
• Casanova C, Cote C, de Torres JP, Aguirre-Jaime A, Marin JM, Pinto-Plata V, Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005 Mar 15; 171(6):591–597.
   Google Scholar
• Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 2004 Jan; 23(1):28–33.
   PubMed Web of Science ®Google Scholar
• Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 2003 Feb 15; 167(4):544–549.
   PubMed Web of Science ®Google Scholar
• Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002 May; 121(5):1434–1440.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Celli BR. Systemic manifestations and co-morbidities of COPD. Eur Respir J 2009 May; 33(5):1165–1185.
   PubMed Web of Science ®Google Scholar
• Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005 Jul; 82(1):53–59.
   PubMed Web of Science ®Google Scholar
• Gray-Donald K, Gibbons L, Shapiro SH, Macklem PT, Martin JG. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996 Mar; 153(3):961–966.
   PubMed Web of Science ®Google Scholar
• Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999 Dec; 160(6):1856–61.
   PubMed Web of Science ®Google Scholar
• Martinez FJ, Foster G, Curtis JL, Criner G, Weinmann G, Fishman A, Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 2006 Jun 15; 173(12):1326–1334.
   PubMed Web of Science ®Google Scholar
• Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998 Jun; 157(6 Pt 1):1791–1797.
   PubMed Web of Science ®Google Scholar
• Martinez FJ, Han MK, Andrei AC, Wise R, Murray S, Curtis JL, Longitudinal change in the BODE index predicts mortality in severe emphysema. Am J Respir Crit Care Med 2008 Sep 1; 178(5):491–499.
   PubMed Web of Science ®Google Scholar
• Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005 Nov; 60(11):925–931.
   PubMed Web of Science ®Google Scholar
• Hogg JC, Chu FS, Tan WC, Sin DD, Patel SA, Pare PD, Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology. Am J Respir Crit Care Med 2007 Sep 1; 176(5):454–459.
   PubMed Web of Science ®Google Scholar
• Dahl M, Vestbo J, Lange P, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007 Feb 1; 175(3):250–255.
   PubMed Web of Science ®Google Scholar
• Donaldson GC. C-reactive protein: does it predict mortality? Am J Respir Crit Care Med 2007 Feb 1; 175(3):209–210.
   PubMed Web of Science ®Google Scholar
• Man SF, Connett JE, Anthonisen NR, Wise RA, Tashkin DP, Sin DD. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 2006 Oct; 61(10):849–853.
   PubMed Web of Science ®Google Scholar
• de Torres JP, Pinto-Plata V, Casanova C, Mullerova H, Cordoba-Lanus E, Muros de Fuentes M, C-reactive protein levels and survival in patients with moderate to very severe COPD. Chest 2008 Jun; 133(6):1336–1343.
   PubMed Web of Science ®Google Scholar
• Man SF, Xing L, Connett JE, Anthonisen NR, Wise RA, Tashkin DP, Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD? Eur Respir J 2008 Dec; 32(6):1451–1457.
   PubMed Web of Science ®Google Scholar
• Christakis NA, Escarce JJ. Survival of Medicare patients after enrollment in hospice programs. N Engl J Med 1996 Jul 18; 335(3):172–178.
   PubMed Web of Science ®Google Scholar
• Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med 2000 Feb; 161(2 Pt 1):381–390.
   PubMed Web of Science ®Google Scholar
• Gartlehner G, Hansen RA, Carson SS, Lohr KN. Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes. Ann Fam Med 2006 May-Jun; 4(3):253–262.
   PubMed Web of Science ®Google Scholar
• Sin DD, Wu L, Anderson JA, Anthonisen NR, Buist AS, Burge PS, Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax 2005 Dec; 60(12):992–997.
   PubMed Web of Science ®Google Scholar
• Macie C, Wooldrage K, Manfreda J, Anthonisen NR. Inhaled corticosteroids and mortality in COPD. Chest 2006 Sep; 130(3):640–646.
   PubMed Web of Science ®Google Scholar
• Soriano JB, Vestbo J, Pride NB, Kiri V, Maden C, Maier WC. Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice. Eur Respir J 2002 Oct; 20(4):819–825.
   PubMed Web of Science ®Google Scholar
• Sin DD, Tu JV. Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001 Aug 15; 164(4):580–584.
   PubMed Web of Science ®Google Scholar
• Suissa S. Inhaled steroids and mortality in COPD: bias from unaccounted immortal time. Eur Respir J 2004 Mar; 23(3):391–395.
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Connett JE, Enright PL, Manfreda J. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med 2002 Aug 1; 166(3):333–339.
   PubMed Web of Science ®Google Scholar
• Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med 1980 Sep; 93(3):391–398.
   PubMed Web of Science ®Google Scholar
• Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet 1981 Mar 28; 1(8222):681–686.
   PubMed Web of Science ®Google Scholar
• Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003 May 22; 348(21):2059–2073.
   PubMed Web of Science ®Google Scholar
• Naunheim KS, Wood DE, Mohsenifar Z, Sternberg AL, Criner GJ, DeCamp MM, Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg 2006 Aug; 82(2):431–443.
   PubMed Web of Science ®Google Scholar
• Hosenpud JD, Bennett LE, Keck BM, Edwards EB, Novick RJ. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998 Jan 3; 351(9095):24–27.
   PubMed Web of Science ®Google Scholar
• Stavem K, Bjortuft O, Borgan O, Geiran O, Boe J. Lung transplantation in patients with chronic obstructive pulmonary disease in a national cohort is without obvious survival benefit. J Heart Lung Transplant 2006 Jan; 25(1):75–84.
   PubMed Web of Science ®Google Scholar
• Titman A, Rogers CA, Bonser RS, Banner NR, Sharples LD. Disease-specific survival benefit of lung transplantation in adults: a national cohort study. Am J Transplant 2009 Jul; 9(7):1640–1649.
   PubMed Web of Science ®Google Scholar
• Meyer DM, Bennett LE, Novick RJ, Hosenpud JD. Single vs bilateral, sequential lung transplantation for end-stage emphysema: influence of recipient age on survival and secondary end-points. J Heart Lung Transplant 2001 Sep; 20(9):935–941.
   PubMed Web of Science ®Google Scholar
• Thabut G, Christie JD, Ravaud P, Castier Y, Brugiere O, Fournier M, Survival after bilateral versus single lung transplantation for patients with chronic obstructive pulmonary disease: a retrospective analysis of registry data. Lancet 2008 Mar 1; 371(9614):744–751.
   PubMed Web of Science ®Google Scholar
• Thabut G, Ravaud P, Christie JD, Castier Y, Fournier M, Mal H, Determinants of the survival benefit of lung transplantation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008 May 15; 177(10):1156–1163.
   PubMed Web of Science ®Google Scholar